Kura Oncology Inc.
KURA | NASDAQ
$11.60
-$0.13 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$11.60
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:01 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 67.48M | 53.88M | n/a | n/a | n/a | n/a |
Cost of Revenue | 57K | n/a | 849K | n/a | n/a | 194K |
Gross Profit | 67.43M | 53.88M | -849K | n/a | n/a | -194K |
Operating Income | -303.63M | -193.2M | -165.8M | -139.87M | -131.26M | -91.9M |
Interest Income | 26.77M | 22.85M | 14.72M | 4.25M | 1.21M | 2.8M |
Pretax Income | -278.37M | -171.97M | -152.63M | -135.84M | -130.47M | -89.63M |
Net Income | -278.67M | -173.98M | -152.63M | -135.84M | -130.47M | -89.63M |
Selling & General & Admin | 119.98M | 77.11M | 50.57M | 47.05M | 46.54M | 31.31M |
Research & Development | 251.07M | 169.97M | 115.24M | 92.81M | 84.72M | 60.4M |
Other Expenses | n/a | n/a | -849K | n/a | n/a | n/a |
Operating Expenses | 371.06M | 247.08M | 164.96M | 139.87M | 131.26M | 91.71M |
Interest Expense | 1.51M | 1.62M | 1.55M | 229K | 414K | 578K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 371.11M | 247.08M | 165.8M | 139.87M | 131.26M | 91.9M |
Income Tax Expense | 297K | 2.02M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 87.68M | 86.16M | 73.23M | 66.99M | 66.35M | 53.08M |
Shares Outstanding (Diluted) | 87.68M | 86.16M | 73.23M | 66.99M | 66.35M | 53.08M |
EPS (Basic) | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
EPS (Diluted) | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
EBITDA | -275.83M | -169.5M | -150.23M | -134.85M | -129.49M | -88.85M |
EBIT | -276.86M | -170.35M | -151.08M | -135.61M | -130.05M | -89.05M |
Depreciation & Amortization | 1.03M | 848K | 849K | 759K | 558K | 194K |
Add to Watchlist
Select watchlists to add or remove KURA